Research Brief | Altria Study Finds Limited Impact of Massachusetts Flavor Ban on Adult Smoking Rates

Sep.24.2025
Research Brief | Altria Study Finds Limited Impact of Massachusetts Flavor Ban on Adult Smoking Rates
A replication study by Altria scientists published in AJPM Focus evaluated the effect of Massachusetts’ comprehensive flavored‐tobacco ban,the study found that while Massachusetts’ smoking rate continued to decline after the ban, it did not fall faster than in comparison states without flavor bans. Overall, Massachusetts fell from about 14.1% to 10.7%, while comparison states fell from 18.5% to 14.8%. The authors conclude that, for adult smoking prevalence, no additional net decline attributable

The 2025 AJPM Focus paper, “The Behavioral Impact of the Massachusetts Flavored Tobacco Products Ban on Cigarette Smoking Among Adults Aged ≥21 Years,” assessed the ban’s impact using 2017–2022 BRFSS data and a difference-in-differences (DiD) design. Massachusetts (ban in June 2020) served as the treatment group, and U.S. states without flavor bans served as controls. The analysis compared pre- vs post-ban changes in adult smoking rates.

 

Research Brief | Altria Study Finds Limited Impact of Massachusetts Flavor Ban on Adult Smoking Rates
Image source: Altria

 


 

 

Key Findings

 

Overall trend:

 

  • Massachusetts adult smoking: 14.1% (2017) → 10.7% (2022)
  • Comparison states: 18.5% (2017) → 14.8% (2022)
  • Annual decline rates shifted: in Massachusetts, about 6%/year pre-ban slowed to 2%/year post-ban; in comparison states, about 3%/year pre-ban accelerated to 5%/year post-ban.

 

Primary DiD results (adjusted for demographics and year fixed effects):

 

  • Time effect AOR = 1.05 (95% CI: 1.00–1.11, p = 0.0428)
  • Treatment effect AOR = 0.89 (0.84–0.95, p = 0.0002)
  • DiD estimate = 0.94 (0.85–1.03, p = 0.1621) → not significant
  • Multiple sensitivity checks were also not significant (e.g., ≥25 years only: AOR = 0.91, p = 0.0599).
  • Scenario consideration: If roughly one-third of menthol smokers had quit due to the ban, Massachusetts smoking prevalence might have dropped to ≈7% by 2022; such a step-change did not occur.

 

Conclusions

 

With an extended observation window through 2022 and a focus on legal-age adults (≥21), the study did not find evidence that Massachusetts’ flavor ban produced a relative additional decline in adult smoking compared with non-ban states. The authors suggest continued evaluation of initiation, cessation/substitution, DIY flavoring, and illicit supply as potential behavioral and market dynamics that may offset nominal policy effects.

 

Limitations (as stated by the authors)

 

Self-report bias; unobserved, time-varying factors (e.g., state-level COVID-19 responses; Massachusetts’ concurrent tobacco/vaping policies such as temporary EVALI-era sales suspensions, a 75% e-cigarette tax, smoke-free air laws, and funding) may have influenced smoking rates.

 


 

 

Article Information

 

 

Title: The Behavioral Impact of the Massachusetts Flavored Tobacco Products Ban on Cigarette Smoking Among Adults Aged ≥21 Years

Journal: AJPM Focus, 2025, 4(5):100364

Study type: Replication study; Open Access (CC BY-NC-ND)

Authors: Evan A. Winiger, Pavel N. Lizhnyak, Scott W. Drenkard, Andrea R. Vansickel (all with Altria Client Services LLC)

 

 


 

Disclaimer

 

This summary by 2Firsts is based on a publicly available academic paper and is intended to help non-research readers—especially industry practitioners, policymakers, and media—understand the findings and foster dialogue among science, policy, and industry.

 

Unless otherwise indicated, the methods, data, and conclusions presented reflect the original authors’ views. 2Firsts does not endorse those positions and serves only as an information channel.

 

Given possible limitations in our summarization, inaccuracies may exist. Readers are encouraged to consult the original paper for comprehensive details.

 

2Firsts welcomes constructive discussion and critical thinking. No single study answers every question; open and rational dialogue can advance tobacco harm reduction (THR) and improve consumer health outcomes globally.

 

Contact: info@2firsts.com

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
JUUL2 Sued Within a Week of FDA Authorization as AJ Marketing Alleges Infringement of Programmable Vape Patent
Less than a week after JUUL2 received U.S. FDA marketing authorization on August 28, 2026, JUUL Labs was sued for patent infringement in federal court in Delaware. AJ Marketing LLC filed the complaint on September 3, alleging that both JUUL 1 and JUUL2 infringe U.S. Patent No. 8,851,068 B2. The patent covers aspects of programmable electronic vaporization devices, including controls over dose delivery, usage frequency and operating parameters. The plaintiff is seeking reasonable royalties and ongoing royalties tied to the remaining life of the patent. JUUL has not yet publicly responded to the case.
Sep.10
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
Malaysia’s Vape Rules Face Review as Health Minister Dzulkefly Ahmad Addresses Dropped Nicotine Appeal
According to Free Malaysia Today on August 26, 2026, Malaysia’s Health Minister Dzulkefly Ahmad said the Health Ministry would explain the government’s decision to withdraw its appeal against a High Court ruling involving the exemption of liquid nicotine used in vape products from the Poisons List. The High Court previously ruled that the exemption decision was irrational. Dzulkefly said withdrawing the appeal did not mean the government would stop regulating vaping, and that future regulatory approaches would continue under existing legal frameworks.
Aug.28
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Kelly White Bets on Female Consumers as Nicotine Pouch Competition Intensifies | 2Firsts Interview
Swedish nicotine pouch brand Kelly White is building its strategy around adult female consumers. Founder and CEO Sophia Wilsby told 2Firsts that women accounted for around 70% of the brand’s repeat customers on HAYPP in Sweden in 2025. The interview explores female consumer segmentation, product and design differentiation, gender stereotypes, packaging regulation, and how independent brands can compete with global players such as ZYN and VELO while considering funding, partnerships and future ownership options.
Business
Sep.24
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
IQOS Enters Kantar BrandZ Global Top 100 for First Time, Valued at $36.6 Billion and Ranked No. 74
Philip Morris International’s IQOS has entered the Kantar BrandZ Top 100 Most Valuable Global Brands for the first time, ranking No. 74 with a brand value of $36.634 billion and becoming one of only three newcomers to the 2026 ranking. Kantar said the combined value of the Global Top 100 reached $13.1 trillion, up 22% year on year, while the threshold for entry rose to a record high. PMI says IQOS has more than 35 million users worldwide and surpassed $10 billion in annual net revenues within a decade of launch.
Sep.03
 PMI Opens Generative AI Center in Portugal to Support Global Operations
PMI Opens Generative AI Center in Portugal to Support Global Operations
According to information released by Portugal’s Trade & Investment Agency (AICEP) in July 2026, Philip Morris International (PMI) has established a global Generative Artificial Intelligence Factory (GenAI Factory) at its Portuguese subsidiary Tabaqueira. The center will support PMI’s global operations by developing and deploying AI solutions focused on industrial process optimization, data analytics, operational automation and AI application development. The initiative strengthens Portugal’s role in PMI’s global technology and innovation network.
Aug.27
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts Hosts U.S. Market Mid-Year Briefing: Companies Need to Reassess Product and Market-Access Strategies
2Firsts held its 2026 U.S. Market Compliance and Development Mid-Year Briefing in Shenzhen, China, on July 28. The discussion examined how state-level requirements, proposed foreign-establishment registration rules and expanding supply-chain responsibilities are changing product and investment decisions in the U.S. tobacco and nicotine market.
Jul.29